May 25 |
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
|
May 13 |
MacroGenics: Strong Likelihood Bad News Has Caused Overreaction (Rating Upgrade)
|
May 12 |
US$15.10: That's What Analysts Think MacroGenics, Inc. (NASDAQ:MGNX) Is Worth After Its Latest Results
|
May 10 |
Macrogenics Stock Drops 77% After Study Deaths
|
May 10 |
Macrogenics Inc (MGNX) Q1 2024 Earnings: Misses Revenue Estimates Amidst Ongoing Clinical ...
|
May 10 |
MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript
|
May 10 |
MacroGenics crashes after mid-stage data for prostate cancer drug
|
May 10 |
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
|
May 10 |
MacroGenics, Inc. (MGNX) Q1 2024 Earnings Call Transcript
|
May 9 |
MacroGenics GAAP EPS of -$0.84 misses by $0.19, revenue of $9.1M misses by $5.76M
|